Lumexa Imaging Holdings, Inc. (LMRI) Financial Ratio Screen

NASDAQ Healthcare United States USD 991M
RATIOS FAIL*
Automated financial screen · activity assessed separately
Lumexa Imaging Holdings, Inc. (LMRI) is potentially non-compliant in the automated ratio model. The company's debt ratio of 54.5% exceeds the 30% MSCI new-inclusion threshold relative to total assets. Lumexa Imaging Holdings, Inc. operates in the Healthcare sector.

Follow screening changes

Email alerts are not currently available. Bookmark this page and check the financial period and retrieval date when reviewing a result.

MSCI new-inclusion financial-ratio snapshot

LMRI financial screening at a glance

RATIOS FAIL*Financial ratios shown separately from business review — not a fatwa
Debt ratio
54.5%
Fail vs 30%
Cash ratio
3.3%
Pass vs 30%
Receivables + cash
11.9%
Pass vs 30%
Impermissible income
N/A
Not available vs 5%

Calculation date: 2026-10-15. Financial period used: December 2025. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleFinancial criteria not metAt least one available ratio exceeds its threshold
FTSE/Yasaar-styleFinancial criteria not metAt least one available ratio exceeds its threshold
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2025Calculation date2026-10-15S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (Medical Devices) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style debt and cash reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 54.5%
/ 30%
3.3%
/ 30%
11.9%
/ 30%
N/A RATIOS FAIL*
FTSE 54.5%
/ 33%
3.3%
/ 33%
11.9%
/ 50%
N/A RATIOS FAIL*

Financial Highlights

EPS
currency unverified -0.37
Dividend Yield
0.0%
P/B Ratio
1.6
EV/EBITDA
24.3
EV: USD 1.9B
Revenue
USD 1.0B
Growth: 5.1%
Current Ratio
1.4

Profitability

Gross Margin 14.8%
Operating Margin 3.2%
Net Margin -2.7%

Cash Flow & Balance Sheet

Operating Cash FlowUSD 17M
Free Cash FlowUSD -6M
Total DebtUSD 963M
Debt-to-Equity158.6
Current Ratio1.4
Total AssetsUSD 1.8B

Price & Trading

Last Close$10.10
50-Day MA$11.27
200-Day MA$11.74
Avg Volume433K
52-Week Range
$6.45
$19.45

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-10-05 for the financial period December 2025. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About Lumexa Imaging Holdings, Inc. (LMRI)

CEO
Ms. Caitlin Zulla
Employees
5,000
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap (listing currency)
USD 991M
Currency
USD

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is Lumexa Imaging Holdings, Inc. (LMRI) halal to invest in?

The current automated result is Financial criteria not met or an activity exclusion was detected. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is Lumexa Imaging Holdings, Inc.'s debt ratio?

Lumexa Imaging Holdings, Inc.'s debt ratio is 54.5% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are Lumexa Imaging Holdings, Inc.'s key financial metrics?

Lumexa Imaging Holdings, Inc. has a market capitalization of USD 991M in its listing currency, and revenue of USD 1.0B. The company maintains a gross margin of 14.8% and a net margin of -2.7%.

How often is the screening data updated?

Calculation date: 2026-10-15. Financial period: December 2025. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.